Reportlinker finds all market research
reports published by official sources!
- Home
- Companies
- Companies in M
- Merrill Lynch International
- Merrill Lynch International - Company Report for Year 2012
Merrill Lynch International - Company Report for Year 2012
- This 17-page company report was published in June 2012.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Sam
(866) 682 9815
Share
Drug And Medication Industry in China : Latest Downloads
Company Report: Drug for Year 2013
- Company report
- April 2013
- 23 pages
Company Report: Anti-inflammatory for Year 2013
- Company report
- April 2013
- 2 pages
Company Report: Drug and Medication for Year 2013
- Company report
- March 2013
- 3 pages
- by Governmental Agency
... Bioequivalence recommendations for metronidazole vaginal gel. The guidance provides specific recommendations on the design of bioequivalence (be) studies to support abbreviated new drug applications (andas ...
Company Report: Drug And Medication For Year ...
3 months agoCompany Report: Drug For Year 2013
4 months agoCompany Report: Drug And Medication For Year ...
4 months agoCompany Report: Drug And Medication For Year ...
5 months agoCompany Report: Drug And Medication For Year ...
6 months agoSpectrum Pharmaceuticals Inc. - Investment An ...
6 months agoCompany Report: Drug And Medication For Year ...
6 months agoMarket Figures
Drug And Medication Key Market Figures In China
3 months ago
More Reports:
Drug and Medication in Australia (22)
Company Reports
Drug And Medication Industry in China : Latest Reports
Peritoneal Tumor - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Peritoneal Tumor - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Peritoneal Tumor - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
World Therapy: Metastatic Melanoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Metastatic Melanoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
Pathology Industry: Chronic Lymphocytic Leukemia (CLL) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
More Reports:
Drug and Medication in China (129)
Reportlinker.com © Copyright 2013. All rights reserved.
